advertisement

HaagStreit

11.9 Gene therapy (53)

Showing records 1 to 25

Display all abstracts in classification 11.9 Gene therapy

Search within classification 11.9 Gene therapy
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Bosco A
Molecular Therapy 2018; 26: 2379-2396
78798 Effects of Lentivirus-Mediated C3 Expression on Trabecular Meshwork Cells and Intraocular Pressure
Tan J
Investigative Ophthalmology and Visual Science 2018; 59: 4937-4944
78799 Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma
Hu X
Frontiers in molecular neuroscience 2018; 11: 350
79303 New MiniPromoter Ple345 (NEFL) Drives Strong and Specific Expression in Retinal Ganglion Cells of Mouse and Primate Retina
Simpson EM
Human Genetics and Therapeutics 2019; 30: 257-272
79183 Gene therapy and the adeno-associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations
Ramlogan-Steel CA
Clinical and Experimental Ophthalmology 2018; 0:
79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Chitranshi N
Molecular Therapy 2019; 27: 424-441
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Anderson SR
Molecular Therapy 2018; 26: 2379-2396
78799 Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma
Dai Y
Frontiers in molecular neuroscience 2018; 11: 350
79303 New MiniPromoter Ple345 (NEFL) Drives Strong and Specific Expression in Retinal Ganglion Cells of Mouse and Primate Retina
Korecki AJ
Human Genetics and Therapeutics 2019; 30: 257-272
79183 Gene therapy and the adeno-associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations
Murali A
Clinical and Experimental Ophthalmology 2018; 0:
79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Dheer Y
Molecular Therapy 2019; 27: 424-441
78798 Effects of Lentivirus-Mediated C3 Expression on Trabecular Meshwork Cells and Intraocular Pressure
Fan N
Investigative Ophthalmology and Visual Science 2018; 59: 4937-4944
79183 Gene therapy and the adeno-associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations
Andrzejewski S
Clinical and Experimental Ophthalmology 2018; 0:
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Breen KT
Molecular Therapy 2018; 26: 2379-2396
78799 Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma
Zhang R
Frontiers in molecular neuroscience 2018; 11: 350
79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Mirzaei M
Molecular Therapy 2019; 27: 424-441
79303 New MiniPromoter Ple345 (NEFL) Drives Strong and Specific Expression in Retinal Ganglion Cells of Mouse and Primate Retina
Fornes O
Human Genetics and Therapeutics 2019; 30: 257-272
78798 Effects of Lentivirus-Mediated C3 Expression on Trabecular Meshwork Cells and Intraocular Pressure
Wang N
Investigative Ophthalmology and Visual Science 2018; 59: 4937-4944
79303 New MiniPromoter Ple345 (NEFL) Drives Strong and Specific Expression in Retinal Ganglion Cells of Mouse and Primate Retina
McGill TJ
Human Genetics and Therapeutics 2019; 30: 257-272
78798 Effects of Lentivirus-Mediated C3 Expression on Trabecular Meshwork Cells and Intraocular Pressure
Feng B
Investigative Ophthalmology and Visual Science 2018; 59: 4937-4944
79190 Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection
Wu Y
Molecular Therapy 2019; 27: 424-441
79183 Gene therapy and the adeno-associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations
Dhungel B
Clinical and Experimental Ophthalmology 2018; 0:
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Romero CO
Molecular Therapy 2018; 26: 2379-2396
78799 Overexpression of Optic Atrophy Type 1 Protects Retinal Ganglion Cells and Upregulates Parkin Expression in Experimental Glaucoma
Shang K
Frontiers in molecular neuroscience 2018; 11: 350
78354 Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma
Steele MR
Molecular Therapy 2018; 26: 2379-2396

Issue 20-1

Select Issue


advertisement

Oculus